Zdrowie i gospodarka · 14/07/2025
FDA Requests Public Comment on Proposed Collection of Information for The Real Cost Campaign Outcomes Evaluation Study: Cohort 3
The FDA is seeking public comment on the proposed extension of the The Real Cost Campaign Outcomes Evaluation Study: Cohort 3, a collection of information required under the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →